Terms: = Germ cell tumor AND MSN, P26038, 4478, ENSG00000147065
48 results:
1. TIMP1/CHI3L1 facilitates glioma progression and immunosuppression via NF-κB activation.
Xu J; Wei C; Wang C; Li F; Wang Z; Xiong J; Zhou Y; Li S; Liu X; Yang G; Han L; Zhang J; Zhang S
Biochim Biophys Acta Mol Basis Dis; 2024 Mar; 1870(3):167041. PubMed ID: 38290591
[TBL] [Abstract] [Full Text] [Related]
2. Concurrent Olaparib and Radiation Therapy in Older Patients With Newly Diagnosed Glioblastoma: The Phase 1 Dose-Escalation PARADIGM Trial.
Derby S; Jackson MR; Williams K; Stobo J; Kelly C; Sweeting L; Shad S; Herbert C; Short SC; Williamson A; James A; Nowicki S; Bulbeck H; Chalmers AJ
Int J Radiat Oncol Biol Phys; 2024 Apr; 118(5):1371-1378. PubMed ID: 38211641
[TBL] [Abstract] [Full Text] [Related]
3. Metabolic imaging in recurrent gliomas: comparative performance of 18F-FDOPA, 18F-fluorocholine and 18F-FDG PET/CT.
Sharma A; Garg A; Singh M; Sharma MC; Gupta S; Kunhiparambath H; Tripathi M; Kale SS; Bal C
Nucl Med Commun; 2024 Feb; 45(2):139-147. PubMed ID: 38095139
[TBL] [Abstract] [Full Text] [Related]
4. Morin Hydrate Encapsulation and Release from Mesoporous Silica Nanoparticles for Melanoma Therapy.
Cunha C; Marinheiro D; Ferreira BJML; Oliveira H; Daniel-da-Silva AL
Molecules; 2023 Jun; 28(12):. PubMed ID: 37375331
[TBL] [Abstract] [Full Text] [Related]
5. Enhancing Methotrexate Delivery in the Brain by Mesoporous Silica Nanoparticles Functionalized with cell-Penetrating Peptide using
Shadmani N; Makvandi P; Parsa M; Azadi A; Nedaei K; Mozafari N; Poursina N; Mattoli V; Tay FR; Maleki A; Hamidi M
Mol Pharm; 2023 Mar; 20(3):1531-1548. PubMed ID: 36763486
[TBL] [Abstract] [Full Text] [Related]
6. Identification of Neural Progenitor cell-associated Chemoradiotherapy Resistance Gene Set (
Yang Y; Xu X; Xie Y; Liu Y; Ning C; Ai Y; Lv C; Wei H; Ge X; Yi T; Piao Y; Wang X; Jin X
Curr Pharm Des; 2022; 28(26):2189-2202. PubMed ID: 35718975
[TBL] [Abstract] [Full Text] [Related]
7. Management of immune-related hepatitis in patients being treated with checkpoint inhibitors for metastatic melanoma, a review and case series.
Tew A; Khoja L; Pallan L; Steven N
J Oncol Pharm Pract; 2023 Jul; 29(5):1163-1171. PubMed ID: 35607278
[TBL] [Abstract] [Full Text] [Related]
8. The National Cancer Database: Survival Between Head and Neck Melanoma and Melanoma of Other Regions.
Cabrera CI; Li S; Conic R; Gastman BR
Otolaryngol Head Neck Surg; 2022 Aug; 167(2):286-297. PubMed ID: 34699278
[TBL] [Abstract] [Full Text] [Related]
9. Dissecting tumor Antigens and Immune Subtypes of Glioma to Develop mRNA Vaccine.
Zhong H; Liu S; Cao F; Zhao Y; Zhou J; Tang F; Peng Z; Li Y; Xu S; Wang C; Yang G; Li ZQ
Front Immunol; 2021; 12():709986. PubMed ID: 34512630
[TBL] [Abstract] [Full Text] [Related]
10. Dermoscopic Criteria, Histopathological Correlates and Genetic Findings of Thin Melanoma on Non-Volar Skin.
Massone C; Hofman-Wellenhof R; Chiodi S; Sola S
Genes (Basel); 2021 Aug; 12(8):. PubMed ID: 34440462
[TBL] [Abstract] [Full Text] [Related]
11. Palmitic acid induces insulin resistance by a mechanism associated with energy metabolism and calcium entry in neuronal cells.
Sánchez-Alegría K; Bastián-Eugenio CE; Vaca L; Arias C
FASEB J; 2021 Jul; 35(7):e21712. PubMed ID: 34110637
[TBL] [Abstract] [Full Text] [Related]
12. Dual Modal Imaging-Guided Drug Delivery System for Combined Chemo-Photothermal Melanoma Therapy.
Zhang D; Zhang W; Wu X; Li Q; Mu Z; Sun F; Zhang M; Liu G; Hu L
Int J Nanomedicine; 2021; 16():3457-3472. PubMed ID: 34045853
[TBL] [Abstract] [Full Text] [Related]
13. Angiopep-2 modified lipid-coated mesoporous silica nanoparticles for glioma targeting therapy overcoming BBB.
Zhu J; Zhang Y; Chen X; Zhang Y; Zhang K; Zheng H; Wei Y; Zheng H; Zhu J; Wu F; Piao JG; Zhu Z; Li F
Biochem Biophys Res Commun; 2021 Jan; 534():902-907. PubMed ID: 33162028
[TBL] [Abstract] [Full Text] [Related]
14. Identification of purity and prognosis-related gene signature by network analysis and survival analysis in brain lower grade glioma.
Xiong Z; Xiong Y; Liu H; Li C; Li X
J Cell Mol Med; 2020 Oct; 24(19):11607-11612. PubMed ID: 32869484
[TBL] [Abstract] [Full Text] [Related]
15. National Trends in Surgical Resection of Vestibular Schwannomas.
Ren Y; Sethi RKV; Stankovic KM
Otolaryngol Head Neck Surg; 2020 Dec; 163(6):1244-1249. PubMed ID: 32571146
[TBL] [Abstract] [Full Text] [Related]
16. Angiopep-2-Conjugated "Core-Shell" Hybrid Nanovehicles for Targeted and pH-Triggered Delivery of Arsenic Trioxide into Glioma.
Tao J; Fei W; Tang H; Li C; Mu C; Zheng H; Li F; Zhu Z
Mol Pharm; 2019 Feb; 16(2):786-797. PubMed ID: 30620881
[TBL] [Abstract] [Full Text] [Related]
17. MiR-200c Inhibits the tumor Progression of Glioma via Targeting Moesin.
Qin Y; Chen W; Liu B; Zhou L; Deng L; Niu W; Bao D; Cheng C; Li D; Liu S; Niu C
Theranostics; 2017; 7(6):1663-1673. PubMed ID: 28529643
[TBL] [Abstract] [Full Text] [Related]
18. EpCAM antibody-conjugated mesoporous silica nanoparticles to enhance the anticancer efficacy of carboplatin in retinoblastoma.
Qu W; Meng B; Yu Y; Wang S
Mater Sci Eng C Mater Biol Appl; 2017 Jul; 76():646-651. PubMed ID: 28482574
[TBL] [Abstract] [Full Text] [Related]
19. An msn-PEG-IP drug delivery system and IL13Rα2 as targeted therapy for glioma.
Shi J; Hou S; Huang J; Wang S; Huan W; Huang C; Liu X; Jiang R; Qian W; Lu J; Wang X; Shi W; Huang R; Chen J
Nanoscale; 2017 Jul; 9(26):8970-8981. PubMed ID: 28443896
[TBL] [Abstract] [Full Text] [Related]
20. Verteporfin based silica nanoparticle for in vitro selective inhibition of human highly invasive melanoma cell proliferation.
Rizzi M; Tonello S; Estevão BM; Gianotti E; Marchese L; Renò F
J Photochem Photobiol B; 2017 Feb; 167():1-6. PubMed ID: 28039784
[TBL] [Abstract] [Full Text] [Related]
[Next]
